您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
Junyuan WANG
Junyuan WANG
所属职位: 创始人、总裁兼首席执行官
所属公司:

葆元生物医药科技(杭州)有限公司

Dr. Junyuan Wang is a founder of AnHeart Therapeutics Inc. Dr. Wang has strong leadership experience in global clinical development and medical research acquired through his work at Merck Serono, BMS, Wyeth/Pfizer, The Medicines Company, and Merck & Co. His broad drug development experiences including therapeutic areas such as oncology, cardiovascular, neuroscience, immunology, and hematology. He has a stellar track-record in shaping global drug development strategy. He has played critical support for two successful new drug applications in US and worldwide market authorization. One of the product that he led a team of over 20 people to support NDA has reached annual sale of USD 5 Billion in 2017. He also played critical role in many submissions for label extensions. Besides many interaction with health authorities including FDA, EMA, PMDA and CFDA, he also has rich experience in partnering with key opinion leaders and vendors to foster data-driven decision making.  He is well recognized for his deep understanding in ICH guidelines, GCP compliance, and trial quality control. He serves as global experts for two CFDA/CDE ICH working groups. He also served leadership role in professional societies and in programming committee of scientific conferences.  


微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务